Let me guess the next 6 months. Capital raising at higher SP for pipeline expansion and market penetration followed by shorting/pushing it back down to 30 cents.
Having said this, the tech and management plan seem good. Like all other Australian small biotech companies, how does one predict profitablity?
Let me guess the next 6 months. Capital raising at higher SP for...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
-0.025(3.42%) |
Mkt cap ! $159.9M | |||
| Open | High | Low | Value | Volume |
| 73.0¢ | 73.0¢ | 70.0¢ | $45.61K | 63.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 499 | 70.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 14325 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| GSS (ASX) Chart |